Pharmacodynamic Markers for Choline Kinase Down-Regulation in Breast Cancer Cells

Breast cancer cells have been found to express high levels of choline kinase, which is associated with malignant transformation, invasion, and metastasis. Recent research has led to the development of novel pharmacologic or gene therapeutic interventions for ChoK-targeted inhibition. A study published in the journal Neoplasia investigated the uptake and efflux of [(3)H]choline, a natural substrate of ChoK, and other metabolic indicators of malignancy in ChoK-downregulated cells. The study found that choline uptake in breast epithelial cell lines was ChoK-dependent and that reduced proliferation due to ChoK down-regulation resulted in reduced [(3)H]thymidine uptake and incorporation into DNA. These findings suggest the utility of radiolabeled choline or choline analogs and proliferation imaging agents as pharmacodynamic markers for ChoK-targeted therapies.

Key Takeaways:

• High levels of choline kinase expression are associated with malignant transformation, invasion, and metastasis in breast cancer cells.
• Choline uptake in breast epithelial cell lines is ChoK-dependent and shows reduced proliferation in ChoK-downregulated cells.
• Reduced [(3)H]thymidine uptake was observed due to ChoK down-regulation, consistent with a decreased cell cycle S-phase fraction.
• No change in [(3)H]fluorodeoxyglucose uptake was observed between ChoK-downregulated and control cells.
• Radiolabeled choline or choline analogs and proliferation imaging agents can serve as pharmacodynamic markers for ChoK-targeted therapies.
• The study suggests a ChoK-mediated mechanism for tumor sequestration of choline-based imaging agents.
• The findings have implications for the development of novel pharmacologic or gene therapeutic interventions for breast cancer.

Statistics:

• 48 hours: The time frame in which reduced proliferation results in reduced [(3)H]thymidine uptake and incorporation into DNA.
• 3: The number of cell lines tested, including nonmalignant and malignant breast epithelial cell lines.
• 5: The issue number of the journal Neoplasia where the study was published.
• 477-84: The page numbers of the journal Neoplasia where the study was published.

Sources:

• S. Nimmagadda et al. "Pharmacodynamic markers for choline kinase down-regulation in breast cancer cells." Neoplasia, vol. 11, no. 5, 2009, pp. 477-84.
• Johns Hopkins University, Russell H Morgan Dept. of Radiology and Radiological Science, Baltimore, MD 21231 USA.
• Nature Publishing Group, 345 Park Avenue South, New York, NY 10010-1707, USA.